INTELLIGENCE IN ACTION

HIMSS18 Panel Gets Candid About Prescription Price Transparency

March 22, 2018

In advance of its highly anticipated conference—widely regarded as the world’s largest health information tradeshow—HIMSS posed this question on its homepage: “Are you ready for the next step in health?” Based on the enthusiasm of the more than 40,000 people who traveled to Las Vegas for this year’s show, the answer was a resounding “yes!”

That same excitement and passion for innovation was evident in the panel discussion we hosted in our booth: Bringing Prescription Price Transparency to the Point of Care. Pat Salber from The Doctor Weighs In moderated a lively discussion that included Casey Leonetti of CVS Health, Dr. Lynne Nowak of Express Scripts, Neil Simon of Aprima Medical Software and our very own Tom Skelton.

Our esteemed panelists explored a number of key challenges and opportunities related to prescription price transparency. According to Dr. Nowak, “[Physicians] care about the patient sitting in front of them and whether that patient can afford the medication or whether that patient is getting the best price within their benefits. So giving visibility … not only to the cost of the medication that is the initial choice, but [also to] those therapeutic alternatives is critical.”

In November 2017, Surescripts announced plans to revolutionize the prescription decision-making process with its Real-Time Prescription Benefit and expanded Prior Authorization solutions. Surescripts has joined forces with six electronic health records (EHR) companies, including Allscripts, Aprima, Cerner, Epic and GE Healthcare, and is leveraging information from pharmacy benefit managers (PBMs) CVS Health and Express Scripts to deliver patient-specific benefit and price information to providers in real time at the point of care.

Watch the panel discussion to learn how delivering patient-specific drug benefit and cost information to the point of care is revolutionizing a critical step in the e-prescribing process—all while improving medication adherence, patient care and costs. Then, take a peek at our Real-Time Prescription Benefit webpage. It’s indeed time to take the next step in health.

Related Articles

June 19, 2019

Health Plans and PBMs Team Up to Get Patients Needed Medications Easier and Faster

Anyone who works in health IT knows how gratifying it is when we offer clinicians a tool that is so much better than old processes, and they run with it. And it’s especially transformative when technology replaces a manual process—one that absorbed a great deal of time and resources.  Read more...
May 21, 2019

An Urgent Call for Transformation: Prescribers Need Better Information and a Streamlined Specialty Prescribing Process

Most likely, you or someone you love has been impacted by a complex or chronic illness like cancer or multiple sclerosis. Sadly, these diseases—and the cost of medications to treat them—are on the rise. More than half of specialty drugs cost in excess of $100,000 a year. As a result, spending on branded specialty medications is rising by 10 percent a year and is projected to surpass half of all medication spending by 2022, even though these drugs comprise just a fraction of all prescribed medications.

Read more...
May 20, 2019

Federal Government Issues Final Rule: Part D Plans Must Adopt a Real Time Benefit Tool

On May 16, the Centers for Medicare and Medicaid Services (CMS) issued its final rule: Medicare Advantage and Part D Drug Pricing Final Rule (CMS-4180-F).

We’ve been closely following this proposal as it relates to e-prescribing and the Part D prescription drug plan in particular. The rule is designed to accelerate the use of Real Time Benefit Tools (RTBTs), such as Surescripts Real-Time Prescription Benefit.

Read more...

INTELLIGENCE IN ACTION, DELIVERED TO YOUR INBOX